Berotralstat

From WikiMD's Wellness Encyclopedia

What Is Berotralstat?[edit | edit source]

  • Berotralstat (ORLADEYO) is a plasma kallikrein inhibitor, a prescription medicine used to prevent attacks of Hereditary Angioedema (HAE) in adults and children 12 years of age and older.
Error creating thumbnail:

What are the uses of this medicine?[edit | edit source]

How does this medicine work?[edit | edit source]

  • Berotralstat is a plasma kallikrein inhibitor that binds to plasma kallikrein and inhibits its proteolytic activity.
  • In patients with HAE due to C1-inhibitor (C1-INH) deficiency or dysfunction, normal regulation of plasma kallikrein activity is not present, which leads to uncontrolled increases in plasma kallikrein activity and results in angioedema attacks.
  • Berotralstat decreases plasma kallikrein activity to control excess bradykinin generation in patients with HAE.

Who Should Not Use this medicine ?[edit | edit source]

  • Berotralstat (ORLADEYO) should not be used for treatment of acute HAE attacks.

Is this medicine FDA approved?[edit | edit source]

  • It was approved for use in the United States in 2020.

How should this medicine be used?[edit | edit source]

  • The recommended dosage of Berotralstat is one 150 mg capsule taken orally once daily with food.

What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • This medicine is available as 150 mg, 110 mg Capsules.

This medicine is available in fallowing brand namesː

  • ORLADEYO

What side effects can this medication cause?[edit | edit source]

Common possible side effects of this medicine include:

What special precautions should I follow?[edit | edit source]

  • ORLADEYO should not be used for treatment of acute attacks of HAE.
  • Additional doses or doses of ORLADEYO higher than 150 mg once daily are not recommended.
  • An increase in QT was observed at dosages higher than the recommended 150 mg once daily dosage and was concentration dependent.

What to do in case of emergency/overdose?[edit | edit source]

Taking more than one capsule of ORLADEYO a day may cause serious side effects, including:

  • heart rhythm problems.
  • A heart rhythm problem called QT prolongation can happen in people who take more than one capsule of ORLADEYO a day.
  • This condition can cause an abnormal heart beat.
  • Do not take more than one capsule of ORLADEYO a day.

Can this medicine be used in pregnancy?[edit | edit source]

  • There are insufficient data in pregnant women available to inform drug-related risks with ORLADEYO use in pregnancy.

Can this medicine be used in children?[edit | edit source]

  • The safety and effectiveness of ORLADEYO for prophylaxis to prevent attacks of hereditary angioedema have been established in pediatric patients aged 12 and older.
  • The safety and effectiveness of ORLADEYO in pediatric patients < 12 years of age have not been established.

What should I know about storage and disposal of this medication?[edit | edit source]

  • Store ORLADEYO at room temperature between 68ºF to 77ºF (20ºC to 25ºC).
  • Each carton contains a tamper evident seal.
  • Do not use ORLADEYO if the tamper evident seal is broken or missing.
This article is a stub.

You can help WikiMD by registering to expand it.
Editing is available only to registered and verified users.
WikiMD is a comprehensive, free health & wellness encyclopedia.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju